Events

– Overcoming challenges when moving from non-clinical to clinical Going from non-clinical to clinical is no easy step. That’s why we’ve gathered a few of our key experts from essential product development areas to talk about how to survive and minimize the early risks biotech companies face during the life cycle of product development. Join […]

One World: How the Nordics and the international markets grow together and improve the quality of care   This year, MVA is celebrating it´s 25th year anniversary. The online-only days are fortunately over, and, consequently, we are excited to invite members of Medicon Valley Alliance’ Executive Club to the first 2022 MVA Executive Club Dinner […]

– Breaking through the current limitations Recombinant antibodies are highly specific detection probes in research, diagnostics, and have emerged over the last two decades as the fastest growing class of therapeutic proteins. Mammalian cell lines, especially the Chinese Hamster ovary (CHO) cell line, represent the most widely used expression systems for the production of these […]

Medicon Valley Alliance, together with member company Bioneer, have the pleasure to invite you to the Medicon Valley Alliance R&D Network meeting focusing on Biologics Development and Manufacturing on the 9th of May, 2022. Biologics have paved the way for new treatment paradigms. Dominated by protein and antibody therapeutics, the biologics market now accounts for […]

Connecting with and managing relationships with key opinion leaders (KOLs) is a crucial part of any research-based organization, as well as the surrounding ecosystem. Speaking with the right expert at the right time is invaluable. Breaking through the knowledge silos that exist within the life science industry is critical for any organization. However – finding, […]

Generalized Pairwise Comparison (GPC) is an innovative statistical method used to design and analyze clinical trials to make the best possible use of the data collected. This allows the analysis to take into account several endpoints, providing deeper insights into the net treatment benefits. Specifically, the GPC method enables you to: Assess clinical trials based […]

Members of Medicon Valley Alliance are invited to attend the Ordinary General Meeting 2022 Date: Wednesday April 6th, 2022 Time: 17.00-18.00 Venue: Online   Documents for the Ordinary General Meeting: Convening notice for the Ordinary General Meeting 2022 Medicon Valley Alliance Annual Report 2021 Power of Attorney – Ordinary General Meeting 2022 Bylaws   Registration […]

In collaboration with DiaUnion, DDA invites you to an exclusive day with the important topic “Biobank”. This day will provide you with insight and broaden your understanding on the multidisciplinary world of biobanking. The course aims to facilitate the participants with an interdisciplinary perspective on the historical, technical, legal, and ethical aspects, including the importance […]

Invitation is open to all members Medicon Valley Alliance, Symbion Community, and delegates at BIO-Europe Spring. As part of the Global Delegations Hub for partneringONE at BIO-Europe Spring 2022 we are glad to host a Live reception during BIO Spring 2022 here in Copenhagen. Main purpose is networking and an introduction to Copenhagen Capacity and […]

Medicon Valley Alliance together with member company Miltenyi Biotec have the pleasure to invite you to the 12th meeting of the Medicon Valley Alliance Oncology Network on the 16th of March, 2022. Immuno-oncology is sometimes referred to as the fifth pillar of cancer treatment, alongside surgery, radiotherapy, chemotherapy and precision therapy. The activation and utilization […]

Medicon Valley Alliance, together with Ideon Science Park and Sigma Connectivity, have the pleasure to invite you to the Medicon Valley Alliance Medtech Network meeting on 3rd of March, 2022 in Lund. Prototyping is an essential and fundamental part of medical device development and manufacturing. Not only is it critical for refining the design of […]

The pharmaceutical pipeline is gaining momentum, led by many first-time launchers. But the reality is companies spend >$200MM over three years leading up to launch, and 66% of drugs still don’t meet launch expectations. This looming risk, echoed by general industry pressures, leaves developers and investors alike looking for more advanced commercialisation options that effectively […]

Medicon Valley Alliance, together with Bacthera, have the pleasure to invite you to the Medicon Valley Alliance Microbiome Network meeting on 9th of February, 2022 in Copenhagen. Live biotherapeutic products (LBPs) are living microorganisms administered therapeutically and the human microbiome is an increasingly important avenue of health research. Today, we know that the microbiome plays […]

One of the major recent trends in drug development in oncology, particularly with highly targeted therapy and immunotherapy, is a great concern with efficacy assessment in early phases of development. This was not frequent before the era of precision medicine. As a result, phase 1 trials now routinely have efficacy endpoints and even sample-size justification […]

HALOS and Medicon Valley Alliance invite you to join us for a half-day symposium on how to benefit from using the large-scale research infrastructures such as MAX IV and ESS, and how the unique resources available in the Öresund-Hamburg area could be utilised in life science. During the symposium we will focus on using or […]

– an international outlook and regional challenges  Hologic Global Women’s Health Index is a unique survey based on 120 000+ interviews representing 2.5 billion women and girls. Using the index as a starting point, we discuss possible ways forward for Swedish and Danish women’s health – with a focus on cancer prevention. How can we mitigate the impact […]

Medicon Valley Alliance together with Lund Stem Cell Center, Lund University have the pleasure to invite you the Medicon Valley Alliance R&D Network meeting on 24th of November, 2021 in Lund. Cell and gene therapies are being widely accepted as one of the most transformative innovative trends in biopharmaceuticals. Cell and gene therapies are expected […]

Join us for this live webinar to learn about Molecular Classification-based identification of diagnostic and treatment targets in glioma. Dr. Xiaolong Fan, professor at Beijing Normal University in China will provide a high-level overview of his experience in dealing with the challenges of this project. His team has been pursuing this project for about 15 […]

HealthTech @ Medicon Valley 2021: Commercialisation in Europe Wednesday the 17th of November 8.30 – 13.00 A side event to TechConnect Europe 2021 The Nordics and Medicon Valley feature world-class healthcare and research institutions, highly skilled hardware and software expertise, a thriving game industry and a strong startup scene. To showcase our regional life science, […]

Both Denmark and Sweden, having launched new national life science strategies, have clearly made life science a national strategic priority. But what is the potential for future Danish-Swedish life science collaboration post the COVID-19 pandemic? Where are the synergies, and how do we leverage them for the benefit of science, industry, healthcare and patients alike? […]

With the increasing emphasis on precision medicine, most discussion of diabetes has focused on heterogeneity in type 2 diabetes and distinguishing T2D from monogenic diabetes or atypical forms of diabetes, with the assumption that one can accurately define T1D based on the clinical phenotype. However, this view has been substantially altered by two major changes: […]

The ISO 13485 sets out the requirements for a quality management system specific to the medical devices industry. Why should you have a QMS in the first place, and why use the ISO 13485 standard? We’ll share hands-on experience on what the standard means in practice, as well as ideas on how you can ensure […]

Sino Biological presents: A Comprehensive Overview of the CRO Service Platform Sino Biological is dedicated in providing the scientific community with high-quality recombinant protein and antibody reagents to promote life science research and drug discovery. Several robust recombinant protein expression platforms and antibody discovery methods have been established and are available for customized contracted research […]

Find out about new research related to COVID-19 and the impact on male reproductive function – now and in the future. Organised by ReproUnion where MVA is a partner alongside Region Skåne, Region H, Ferring and the universities in Copenhagen, Lund and Malmö.

– tackling two of the most intensely regulated pathways in one go   Combination products are a fast developing market but a tricky one. Yet this market is really picking up speed. New technologies enable patient care in ever improving levels. But how do you tackle two of the most intensely regulated pathways in one […]